GR3004259T3 - - Google Patents

Info

Publication number
GR3004259T3
GR3004259T3 GR920400559T GR920400559T GR3004259T3 GR 3004259 T3 GR3004259 T3 GR 3004259T3 GR 920400559 T GR920400559 T GR 920400559T GR 920400559 T GR920400559 T GR 920400559T GR 3004259 T3 GR3004259 T3 GR 3004259T3
Authority
GR
Greece
Application number
GR920400559T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/947,334 external-priority patent/US4731382A/en
Application filed filed Critical
Publication of GR3004259T3 publication Critical patent/GR3004259T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G10—MUSICAL INSTRUMENTS; ACOUSTICS
    • G10H—ELECTROPHONIC MUSICAL INSTRUMENTS; INSTRUMENTS IN WHICH THE TONES ARE GENERATED BY ELECTROMECHANICAL MEANS OR ELECTRONIC GENERATORS, OR IN WHICH THE TONES ARE SYNTHESISED FROM A DATA STORE
    • G10H2250/00—Aspects of algorithms or signal processing methods without intrinsic musical character, yet specifically adapted for or used in electrophonic musical processing
    • G10H2250/055—Filters for musical processing or musical effects; Filter responses, filter architecture, filter coefficients or control parameters therefor
    • G10H2250/125—Notch filters
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR920400559T 1986-12-29 1992-04-02 GR3004259T3 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/947,334 US4731382A (en) 1986-12-29 1986-12-29 Lipoxygenase inhibitory phenylalkanohydroxamic acids
US07/133,601 US4861798A (en) 1986-12-29 1987-12-22 Lipoxygenase inhibitory compounds

Publications (1)

Publication Number Publication Date
GR3004259T3 true GR3004259T3 (el) 1993-03-31

Family

ID=26831511

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920400559T GR3004259T3 (el) 1986-12-29 1992-04-02

Country Status (8)

Country Link
US (1) US4861798A (el)
EP (1) EP0273451B1 (el)
JP (1) JPS63264442A (el)
AU (1) AU614949B2 (el)
DE (1) DE3777986D1 (el)
ES (1) ES2041261T3 (el)
GR (1) GR3004259T3 (el)
NZ (1) NZ223104A (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02196767A (ja) * 1988-10-11 1990-08-03 Kyowa Hakko Kogyo Co Ltd ヒドロキサム酸誘導体
US5096919A (en) * 1989-01-05 1992-03-17 Ciba-Geigy Corporation Pyrrolylphenyl-substituted hydroxamic acid derivatives
US4960787A (en) * 1989-02-06 1990-10-02 Ciba-Geigy Corporation Certain pyrrolyl-substituted hydroxamic acid derivatives
JP3065636B2 (ja) * 1989-06-29 2000-07-17 塩野義製薬株式会社 ［ジ―ｔｅｒｔ―ブチル（ヒドロキシ）フェニルチオ］置換ヒドロキサム酸誘導体
US5093363A (en) * 1989-08-22 1992-03-03 Shionogi & Co., Ltd. 2,4,6-substituted phenol derivatives
US5476873A (en) * 1990-07-25 1995-12-19 Abbott Laboratories Acetylene derivatives having lipoxygenase inhibitory activity
JPH0819069B2 (ja) * 1990-07-25 1996-02-28 アボツト・ラボラトリーズ リポキシゲナーゼ阻害活性を有するアセチレン誘導体
US5281623A (en) * 1990-08-27 1994-01-25 Eli Lilly And Company Method for treating inflammation
GB9024820D0 (en) * 1990-11-15 1991-01-02 Davies Michael J Pharmaceutical compositions
US5280046A (en) * 1991-02-22 1994-01-18 The University Of Colorado Foundation, Inc. Method of treating type I diabetes
US5117054A (en) * 1991-09-26 1992-05-26 Ortho Pharmaceutical Corporation N-hydroxy, N-methyl propanamides
US5208364A (en) * 1992-06-25 1993-05-04 Bristol-Myers Squibb Co. Antibiotic 5-lipoxygenase inhibitors
EP0725059B1 (en) * 1993-10-19 2001-01-17 Sumitomo Pharmaceuticals Company, Limited 2,3-diaminopropionic acid derivative
DK0730588T3 (da) * 1993-11-26 1997-12-08 Pfizer Isoxazolinforbindelser som antiinflammatoriske midler
US5804601A (en) * 1995-04-10 1998-09-08 Takeda Chemical Industries, Ltd. Aromatic hydroxamic acid compounds, their production and use
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US20030129724A1 (en) 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
WO2006102557A2 (en) 2005-03-22 2006-09-28 The President And Fellows Of Harvard College Treatment of protein degradation disorders
CN101400362B (zh) 2006-02-14 2016-10-12 哈佛大学校长及研究员协会 双官能组蛋白去乙酰化酶抑制剂
JP5497431B2 (ja) * 2006-05-03 2014-05-21 プレジデント アンド フェローズ オブ ハーバード カレッジ ヒストンデアセチラーゼおよびチューブリンデアセチラーゼ阻害剤
JP5309318B2 (ja) * 2007-03-09 2013-10-09 国立大学法人 岡山大学 エステル、カルボン酸及びアミドの製造方法
JP5665740B2 (ja) 2008-07-23 2015-02-04 プレジデント アンド フェローズ オブ ハーバード カレッジ デアセチラーゼ阻害剤およびその使用
EP3791880A1 (en) 2009-04-29 2021-03-17 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising epa
US8716344B2 (en) 2009-08-11 2014-05-06 President And Fellows Of Harvard College Class- and isoform-specific HDAC inhibitors and uses thereof
CN102526213A (zh) * 2012-01-31 2012-07-04 庞树有 治疗慢性结肠炎的中药组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2397508A (en) * 1943-05-29 1946-04-02 Standard Oil Co Hydroxamic acids
JPS5946244A (ja) * 1982-09-09 1984-03-15 Nissan Chem Ind Ltd ヒドロキサム酸誘導体およびその製造法
JPS61118346A (ja) * 1984-11-12 1986-06-05 Yamanouchi Pharmaceut Co Ltd ω−（ジヒドロキシフエニル）アルカンカルボン酸誘導体
ATE80611T1 (de) * 1985-03-16 1992-10-15 Wellcome Found Aryl-derivate.
JPS61289064A (ja) * 1985-04-03 1986-12-19 ユ−エスヴイ−　フア−マシユ−テイカル　コ−ポレ−シヨン アラキドン酸代謝経路の調節剤としてのヒドロキザメ−ト類
US4792560A (en) * 1985-04-03 1988-12-20 Rorer Pharmaceutical Corporation Quinoline hydroxamates and their use as modulators of arachidonic acid metabolic pathways
US4604407A (en) * 1985-04-04 1986-08-05 E. R. Squibb & Sons, Inc. Hydroxamates
US4731382A (en) * 1986-12-29 1988-03-15 Bristol-Myers Company Lipoxygenase inhibitory phenylalkanohydroxamic acids

Also Published As

Publication number Publication date
DE3777986D1 (de) 1992-05-07
EP0273451A3 (en) 1989-05-03
NZ223104A (en) 1991-05-28
AU8310387A (en) 1988-06-30
EP0273451A2 (en) 1988-07-06
JPS63264442A (ja) 1988-11-01
AU614949B2 (en) 1991-09-19
ES2041261T3 (es) 1993-11-16
EP0273451B1 (en) 1992-04-01
US4861798A (en) 1989-08-29

Similar Documents

Publication Publication Date Title
IN169326B (el)
US4723934B1 (el)
GR3004259T3 (el)
US4685239B1 (el)
DE8703659U1 (de) Verschlußkappe für eine Küvette
DE3690749T1 (el)
AU6562586A (el)
IN167616B (el)
DE8700082U1 (de) Skischuh
DE8705627U1 (de) Gasbeheizter Heisswasserspeicher
IN170124B (el)
AU7131791A (el)
BE905088A (el)
AU4596985A (el)
AU6053586A (el)
AU5173485A (el)
IN167221B (el)
IN167044B (el)
IN164893B (el)
IN163978B (el)
AU5703286A (el)
AU5130285A (el)
AU4946385A (el)
BE905178A (el)
AU6098786A (el)